Appendix Table 2.

Median, percentiles and geometric means with 95% confidence intervals of different biochemical criterion at baseline population

Blood biochemical items	Group	n	Mean±Sth.	Median	5%	25%	75%	95%	Geometric Means (95%CI)	ρ− Value ^*

Total Cholesterol (mmol/L)	Case	622	4.93±0.97	4.89	3.44	4.29	5.52	6.50	4.83 (4.76–4.91)	<0.05
Total Cholesterol (mmol/L)	Control	622	4.69±0.89	4.64	3.40	4.12	5.17	6.20	4.61 (4.54–4.68)	<0.05
Triglyceride (mmol/L)	Case	622	2.44±1.82	1.90	0.89	1.39	2.88	5.96	2.04 (1.96–2.14)	<0.05
Triglyceride (mmol/L)	Control	622	1.72±1.17	1.41	0.70	1.04	2.04	3.73	1.49 (1.43–1.55)	<0.05
High-density Lipoprotein cholesterol (mmol/L)	Case	622	1.26±0.34	1.22	0.84	1.03	1.43	1.78	1.22 (1.20–1.24)	<0.05
High-density Lipoprotein cholesterol (mmol/L)	Control	622	1.35±0.42	1.31	0.84	1.09	1.54	2.02	1.30 (1.27–1.33)	<0.05
Low-density Lipoprotein cholesterol (mmol/L)	Case	622	2.82±1.02	2.74	1.26	2.04	3.58	4.14	2.61 (2.53–2.70)	0.72
Low-density Lipoprotein cholesterol (mmol/L)	Control	622	2.75±0.92	2.75	1.23	2.13	3.37	4.18	2.58 (2.50–2.66)	0.72
Serum Uric Acid (μmol/L)	Case	622	351.0±84.78	347.00	228.00	293.00	398.00	492.00	341.0 (334.6–347.6)	<0.05
Serum Uric Acid (μmol/L)	Control	622	325.92±71.97	322.50	220.00	275.00	368.00	463.00	318.1 (312.5–323.7)	<0.05

: ρ represent the covariance significant test for geometric means, adjusted by: Age at diagnosis (<40, 40–49, 50–59, 60–69, ≥70), gender (male/female), BMIs (≤18.5, 18.5–23.9, 24.0–27.9, ≥28.0), family history of diabetes (yes or no), smoking index, (no smoking, 0–6.3, 6.4–14.0, 14.1–23.2, ≥23.3), lifetime total alcohol intake, (no drinking, 0–72.2, 72.3–167.5, 167.5–380.1, ≥380.1), hypertension status (normal, elevated, stage I, stage II).